Table 2.

Relative efficacy data of empagliflozin versus saxagliptin and sitagliptin derived from the ITC [27]

Comparison empagliflozin vs	Cardiovascular-related mortality	All-cause mortality	Composite endpoint	Hospitalisation due to heart failure	Non-fatal stroke	Non-fatal myocardial infarction
Saxagliptin	0.60 (0.46, 0.80)	0.61 (0.49, 0.76)	0.86 (0.72, 1.03)	0.51 (0.37, 0.70)	1.12 (0.76, 1.63)	0.92 (0.69, 1.20)
Sitagliptin	0.60 (0.46, 0.79)	0.67 (0.54, 0.83)	0.87 (0.73, 1.04)	0.65 (0.47, 0.90)	–	–